Autologous cells derived from different sources and administered using different regimens for 'no‐option' critical lower limb ischaemia patients
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Autologous Cells Derived From Different Sources and Administered Using Different Regimens for 'no‐option' Critical Lower Limb Ischaemia Patients." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439237/all/Autologous_cells_derived_from_different_sources_and_administered_using_different_regimens_for_'no‐option'_critical_lower_limb_ischaemia_patients.
Autologous cells derived from different sources and administered using different regimens for 'no‐option' critical lower limb ischaemia patients. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439237/all/Autologous_cells_derived_from_different_sources_and_administered_using_different_regimens_for_'no‐option'_critical_lower_limb_ischaemia_patients. Accessed February 8, 2025.
Autologous cells derived from different sources and administered using different regimens for 'no‐option' critical lower limb ischaemia patients. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439237/all/Autologous_cells_derived_from_different_sources_and_administered_using_different_regimens_for_'no‐option'_critical_lower_limb_ischaemia_patients
Autologous Cells Derived From Different Sources and Administered Using Different Regimens for 'no‐option' Critical Lower Limb Ischaemia Patients [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 February 08]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439237/all/Autologous_cells_derived_from_different_sources_and_administered_using_different_regimens_for_'no‐option'_critical_lower_limb_ischaemia_patients.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Autologous cells derived from different sources and administered using different regimens for 'no‐option' critical lower limb ischaemia patients
ID - 439237
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439237/all/Autologous_cells_derived_from_different_sources_and_administered_using_different_regimens_for_'no‐option'_critical_lower_limb_ischaemia_patients
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -